Hy2Care develops a so called “injectable plaster” to repair the cartilage surface.
Hy2Care B.V. is a spin off company from the University of Twente and aims to introduce the first cure for osteoarthritis in patient care. Osteoarthritis is one of the most common degenerative joint disease that leads to damage of the cartilage surface. Hy2Care develops a so called “injectable plaster” to repair the cartilage surface. This plaster is injected during an arthroscopic surgery on the cartilage surface. The “plaster” helps to calm the wound and following the repair of the cartilage. The Pre-Seed Grant enables Hy2Care to test the concept of the “ïnjectable plaster” in horses with cartilage damage. After this project patient studies will be started.